Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Share-based Compensation: 2020-2025

Historic Share-based Compensation for iSpecimen (ISPC) over the last 6 years, with Sep 2025 value amounting to $1,797.

  • iSpecimen's Share-based Compensation fell 97.24% to $1,797 in Q3 2025 from the same period last year, while for Sep 2025 it was $30,473, marking a year-over-year decrease of 89.32%. This contributed to the annual value of $249,675 for FY2024, which is 45.68% down from last year.
  • As of Q3 2025, iSpecimen's Share-based Compensation stood at $1,797, which was down 0.33% from $1,803 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Share-based Compensation ranged from a high of $399,821 in Q3 2021 and a low of $1,797 during Q3 2025.
  • For the 3-year period, iSpecimen's Share-based Compensation averaged around $52,106, with its median value being $30,568 (2023).
  • Its Share-based Compensation has fluctuated over the past 5 years, first skyrocketed by 1,300.66% in 2021, then tumbled by 97.24% in 2025.
  • Quarterly analysis of 5 years shows iSpecimen's Share-based Compensation stood at $171,833 in 2021, then tumbled by 73.73% to $45,138 in 2022, then soared by 139.53% to $108,119 in 2023, then slumped by 89.85% to $10,972 in 2024, then tumbled by 97.24% to $1,797 in 2025.
  • Its last three reported values are $1,797 in Q3 2025, $1,803 for Q2 2025, and $15,901 during Q1 2025.